Pharmacokinetic assessment of the synthesized chalcones and aurone analogs (1–22)^a.

Compound no.	Mol. formula	Mol wt. (g mol−1)	No. HBAb	No. HBDc	Mol. log Pd	Mol. log Se (mg L−1)	Mol. PSAf Å2	Drug-likeness model score	Lipinski's rule of 5
1	C13H8Br2O3	369.88	3	1	4.42	17.32	36.44	−0.24	Yes
2	C15H9Br2ClO2	413.87	2	1	5.85	0.50	28.69	−0.06	No
3	C16H9Br2F3O2	447.89	2	1	6.19	1.06	28.69	−0.42	No
4	C16H12ClNO5	333.04	5	1	3.26	77.48	74.20	−0.20	Yes
5	C15H9ClFNO4	321.02	4	1	3.37	49.51	66.65	−0.20	Yes
6	C17H15ClN2O4	346.07	4	1	3.37	49.29	69.46	−0.35	Yes
7	C15H9Cl2NO4	336.99	4	1	3.90	11.30	66.65	−0.10	Yes
8	C17H14ClNO4	331.06	4	1	4.31	10.58	66.65	−0.55	Yes
9	C13H8ClNO4S	308.99	5	1	2.68	142.36	67.67	−0.17	Yes
10	C19H18ClNO6	391.08	6	1	4.11	9.72	81.79	0.04	Yes
11	C23H18ClNO6	439.08	6	1	4.61	6.00	81.60	−0.25	Yes
12	C15H7Br2ClO2	411.85	2	0	5.75	0.09	21.36	−0.56	No
13	C16H7Br2F3O2	445.88	2	0	6.09	0.39	21.36	−0.92	No
14	C13H6Br2O3	367.87	3	0	4.31	6.64	29.11	−0.83	Yes
15	C17H13Br2NO2	420.93	2	0	5.22	2.03	24.17	−0.81	No
16	C15H7Cl2NO4	334.98	4	0	3.86	2.65	59.32	−0.66	Yes
17	C15H7ClFNO4	319.00	4	0	3.33	18.97	59.32	−0.70	Yes
18	C17H12ClNO4	329.05	4	0	4.25	2.11	59.32	−1.01	Yes
19	C13H6ClNO4S	306.97	5	0	2.72	65.60	60.34	−0.82	Yes
20	C16H10ClNO5	331.02	5	0	3.22	25.75	66.87	−0.77	Yes
21	C19H16ClNO6	389.07	6	0	3.89	3.49	74.46	−0.35	Yes
22	C23H16ClNO6	437.07	6	0	4.39	2.59	74.27	−0.59	Yes

^aThe table above depicts all the Lipinski's RO5 components, i.e.

^bNumber of hydrogen-bond acceptors.

^cNumber of hydrogen-bond donors.

^dOctanol–water partition coefficient.

^eMeasured solubility.

^fTotal polar surface area.